Patterns of renal involvement in a cohort of patients with inflammatory bowel disease in Egypt

Acta Gastroenterol Belg. 2018 Jul-Sep;81(3):381-385.

Abstract

Background and study aim: Renal complications are frequent extraintestinal manifestations in inflammatory bowel disease (IBD). We aimed in our study to describe the spectrum of renal affection in our IBD patients.

Patients and methods: This study is a retrospective analysis of renal biopsies done for IBD patients who developed renal diseases, at Cairo University Hospital, from June 2005 to Jan. 2016. Results : Among 896 IBD patients, 218 patients (24.3%) developed renal affection. The onset of renal disease mandated renal biopsy at 5.6 ± 7.4 years after IBD diagnosis. Nephrotic range proteinuria was the most common indication for a renal biopsy [81 (37.15%) patients]. Amyloidosis was the most common renal pathological diagnosis [56 patients (25.7%)] followed by immunoglobulin A (IgA) nephropathy [35 patients (16.1%)], focal segmental glome- rulosclerosis (FSGS) [32patients (14.7%)], crescentic glomerulonephritis (CGN) [32 patients (14.7%)], membranous nephropathy (MN) [18 patients (8.25%)], minimal change disease [17 patients (7.7%)], chronic interstitial nephritis (CIN) [10 patients (4.6%)], acute tubular necrosis (ATN) [8 patients (3.7%)], thrombotic microangiopathy (TMA) [6 patients (2.75%)], and acute interstitial nephritis (AIN)[4 patients (1.8%)]. Variable renal histopathology diagnoses did not correlate with age, duration of IBD diagnosis, or drugs used for IBD treatment. Crescentic GN was significantly correlating with ASCA, ANCA-p, and ANCA-c in serum.

Conclusion: Amyloidosis is a common renal pathological diagnosis in our patients, and is followed by IgA nephropathy, and FSGS.

Keywords: IBD; IgA nephropathy; amyloidosis; renal complications.

MeSH terms

  • Acute Disease
  • Adult
  • Amyloidosis / epidemiology
  • Amyloidosis / etiology
  • Amyloidosis / metabolism
  • Amyloidosis / pathology
  • Antibodies, Antineutrophil Cytoplasmic / metabolism
  • Biopsy
  • Egypt / epidemiology
  • Female
  • Glomerulonephritis / epidemiology
  • Glomerulonephritis / etiology
  • Glomerulonephritis / metabolism
  • Glomerulonephritis / pathology
  • Glomerulonephritis, IGA / epidemiology
  • Glomerulonephritis, IGA / etiology
  • Glomerulonephritis, IGA / metabolism
  • Glomerulonephritis, IGA / pathology
  • Glomerulonephritis, Membranous / epidemiology
  • Glomerulonephritis, Membranous / etiology
  • Glomerulonephritis, Membranous / metabolism
  • Glomerulonephritis, Membranous / pathology
  • Glomerulosclerosis, Focal Segmental / epidemiology
  • Glomerulosclerosis, Focal Segmental / etiology
  • Glomerulosclerosis, Focal Segmental / metabolism
  • Glomerulosclerosis, Focal Segmental / pathology
  • Humans
  • Inflammatory Bowel Diseases / complications
  • Inflammatory Bowel Diseases / epidemiology
  • Inflammatory Bowel Diseases / physiopathology*
  • Kidney Cortex Necrosis / epidemiology
  • Kidney Cortex Necrosis / etiology
  • Kidney Cortex Necrosis / metabolism
  • Kidney Cortex Necrosis / pathology
  • Kidney Diseases / epidemiology
  • Kidney Diseases / etiology
  • Kidney Diseases / metabolism
  • Kidney Diseases / pathology*
  • Male
  • Middle Aged
  • Nephritis, Interstitial / epidemiology
  • Nephritis, Interstitial / etiology
  • Nephritis, Interstitial / metabolism
  • Nephritis, Interstitial / pathology
  • Nephrosis, Lipoid / epidemiology
  • Nephrosis, Lipoid / etiology
  • Nephrosis, Lipoid / metabolism
  • Nephrosis, Lipoid / pathology
  • Nephrotic Syndrome / epidemiology
  • Nephrotic Syndrome / etiology
  • Nephrotic Syndrome / metabolism
  • Nephrotic Syndrome / pathology
  • Proteinuria / epidemiology
  • Proteinuria / etiology
  • Proteinuria / metabolism
  • Proteinuria / pathology
  • Renal Insufficiency, Chronic / epidemiology
  • Renal Insufficiency, Chronic / etiology
  • Renal Insufficiency, Chronic / metabolism
  • Renal Insufficiency, Chronic / pathology
  • Retrospective Studies
  • Thrombotic Microangiopathies / epidemiology
  • Thrombotic Microangiopathies / etiology
  • Thrombotic Microangiopathies / metabolism
  • Thrombotic Microangiopathies / pathology

Substances

  • Antibodies, Antineutrophil Cytoplasmic